Publication | Closed Access

Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

Antimicrobial SusceptibilityHealth SciencesAntibioticsIntravenous FosfomycinCarbapenem-resistant Klebsiella PneumoniaeKlebsiella PneumoniaeProspective EvaluationAntimicrobial TherapyAntimicrobial ChemotherapyInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceDrug Resistance